+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Contraceptive Market by Type, Formulation, Mode Of Action, Material Type, Duration, Usage Frequency, Sales Channel, Application, End-User - Global Forecast to 2030- Product Image
Contraceptive Market by Type, Formulation, Mode Of Action, Material Type, Duration, Usage Frequency, Sales Channel, Application, End-User - Global Forecast to 2030- Product Image
Sale

Contraceptive Market by Type, Formulation, Mode Of Action, Material Type, Duration, Usage Frequency, Sales Channel, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083965
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Contraceptive Market grew from USD 38.40 billion in 2024 to USD 41.13 billion in 2025. It is expected to continue growing at a CAGR of 7.41%, reaching USD 58.98 billion by 2030.

Setting the Stage for Evolving Contraceptive Dynamics

The global contraceptive market stands at a pivotal juncture as shifting demographics and evolving health priorities converge to renew interest in family planning solutions. Stakeholders across the value chain-from raw-material suppliers to end-user distribution channels-are navigating a landscape characterized by regulatory intensification, digital transformation, and rising demand for personalized care. Policymakers are revisiting access frameworks to address public health imperatives, while healthcare professionals and advocacy groups champion wider awareness of method efficacy and safety profiles. Against this backdrop, manufacturers and suppliers seek agile strategies to manage cost pressures, differentiate their offerings, and expand presence in both mature and emerging markets.

As technological innovation accelerates, novel delivery systems and non-hormonal approaches are transitioning from concept to commercial viability. Concurrently, sustainability considerations and patient empowerment narratives are reshaping brand positioning and product development roadmaps. This introduction frames the core dynamics informing the subsequent analysis: a thorough examination of market shifts, tariff impacts, nuanced segmentation insights, regional variations, competitive strategies, and actionable recommendations. By synthesizing these strands, decision-makers will gain a comprehensive understanding of the forces driving growth and disruption within the contraceptive sector.

Emerging Forces Reshaping the Contraceptive Environment

The contraceptive landscape is undergoing transformative shifts driven by demographic, technological, and socio-economic forces. Aging populations in developed regions are amplifying demand for long-term and permanent solutions, while younger cohorts champion on-demand options that align with flexible lifestyles. Advances in biomedical research have given rise to implantable devices, transdermal systems, and novel intrauterine technologies designed to optimize efficacy and minimize side effects. At the same time, growing consumer interest in holistic and chemical-free alternatives has elevated non-hormonal barrier methods and herbal contraceptives, prompting manufacturers to diversify their pipelines.

Parallel to product innovation, digital health platforms and telemedicine services are redefining access pathways, enabling remote consultations and streamlined home delivery. Data analytics and wearables offer real-time adherence insights, creating opportunities for personalized interventions and improved outcomes. In response, companies are building ecosystems that integrate patient education, support communities, and value-added services. This section explores how these convergent trends are reshaping competitive dynamics, highlighting the imperative for agility, cross-sector partnerships, and a patient-centric ethos to capture value in an increasingly complex marketplace.

Tariff-Induced Ripples Across US Contraceptive Supply Chains

In 2025, the implementation of revised tariff schedules in the United States has created a cascading effect across global contraceptive supply chains. Increased duties on imported raw materials and finished devices have elevated production costs for manufacturers reliant on offshore component sourcing. As a consequence, several firms have initiated domestic manufacturing investments to mitigate exposure to trade fluctuations and preserve pricing stability. These strategic shifts have prompted realignment among logistics providers, leading to longer lead times but also fostering new alliances with regional producers.

Healthcare providers and payers are grappling with the downstream impact on procurement budgets, negotiating rebates and exploring alternative product portfolios to manage affordability. Regulatory bodies are responding by expediting approvals for domestically produced formulations and offering incentives to stimulate local capacity building. While the tariff policy has introduced short-term cost pressures, it has concurrently galvanized industry stakeholders to fortify supply resilience, diversify sourcing hubs, and explore emerging low-cost regions as part of a broader de-risking strategy.

Unveiling Demand Patterns Through Holistic Market Segmentation

Analyzing the market through multiple segmentation lenses reveals intricate demand patterns and growth vectors. Within the type framework, emergency contraceptives-comprising intrauterine devices and pills-are experiencing heightened uptake amid consumer emphasis on rapid post-coital intervention, while hormonal options such as implantable, injectable, oral, and transdermal contraceptives continue to command substantial share due to established efficacy and familiarity. Non-hormonal barrier methods, herbal Ayurvedic and homeopathic solutions, and natural techniques are gaining traction among health-conscious demographics seeking chemical-free alternatives. Permanent methods like tubal ligation and vasectomy maintain relevance across populations prioritizing long-term planning.

Formulation insights underscore the dominance of oral regimens, led by monophasic and multiphasic pills, alongside growing interest in patches and rings that offer discreet delivery. Mode-of-action analysis indicates that providers are placing renewed emphasis on suppressing ovulation, preventing implantation, and leveraging spermicidal action in tailored therapy regimens. Material preferences are shifting toward non-latex options-nitrile, polyisoprene, and polyurethane-as allergy concerns rise. Duration segmentation differentiates long-term implants and short-term pills, while usage frequency distinctions between on-demand and regular applications illuminate adherence patterns. Sales channels are bifurcating into hospital pharmacy and retail outlets offline, and e-commerce platforms and online pharmacies digitally. Application segments distinguish general use from post-coital needs, and end-user breakdown highlights female subcategories-adolescent, adult, post-menopausal-and a nascent male segment.

Regional Nuances Driving Adoption and Innovation

Regional dynamics are molding adoption trajectories and regulatory responses across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, established reimbursement frameworks and widespread clinical awareness drive high penetration of hormonal methods, while digital health initiatives are accelerating tele-pharmacy and direct-to-consumer channels. The Europe Middle East & Africa region presents a diverse mosaic: western European markets emphasize product innovation and patient education, the Middle East explores localized manufacturing partnerships, and African nations navigate infrastructure gaps with public-private collaborations to improve access.

Across Asia-Pacific, burgeoning middle-class populations and rising healthcare investment are fueling robust demand for both modern and traditional contraceptive solutions. Regulatory agencies in key markets are streamlining approvals for value-added devices, and online sales channels are proliferating amid expanding internet penetration. Cultural sensitivities and localized education efforts continue to influence method mix, driving sustained interest in non-hormonal and herbal options alongside established hormonal formats. This regional tapestry underscores the necessity for adaptive market entry strategies and culturally attuned outreach.

Strategic Postures of Leading Contraceptive Players

Leading pharmaceutical and medical device companies are deploying a range of strategic initiatives to reinforce their market positions. Through mergers, acquisitions, and licensing deals, several key players have expanded their portfolios to include next-generation implantables and non-hormonal alternatives. Concurrently, research collaborations with academic institutions and biotech startups are accelerating the development of novel drug delivery platforms and digital adherence solutions. Marketing investments are increasingly directed toward patient education campaigns, leveraging social media and influencer partnerships to destigmatize contraception and foster brand loyalty.

Manufacturers are also pursuing cost rationalization programs, relocating component assembly to lower-cost regions while maintaining stringent quality controls. Distribution strategies are evolving to integrate omnichannel presence, combining hospital and retail pharmacy networks with direct digital fulfillment. Companies that align clinical evidence generation, regulatory agility, and patient experience design are poised to lead the competitive hierarchy, shaping perception and driving sustainable growth.

Pragmatic Pathways to Seize Market Opportunities

Industry leaders can capitalize on emerging opportunities by embracing a patient-centric innovation agenda that prioritizes non-hormonal research and customizable delivery systems. Strengthening regional manufacturing footprints will mitigate tariff volatility and secure supply continuity, while partnerships with tech providers will enable seamless telehealth integration and data-driven engagement. Realigning go-to-market models to include subscription-based fulfillment and loyalty incentives will foster adherence and recurring revenue streams.

Moreover, targeted outreach programs that address cultural nuances and engage both male and female end users will broaden market penetration. Collaborating with policymakers and advocacy groups to enhance awareness and affordability can create conducive environments for novel product adoption. By implementing cross-functional analytics to monitor market shifts in real time, companies can adjust strategies dynamically, ensuring resilience and sustained competitive advantage in the evolving contraceptive arena.

Rigorous Methodological Foundations Ensuring Data Integrity

This analysis synthesizes primary and secondary research methodologies to ensure comprehensive insights and data integrity. Primary research encompassed in-depth interviews with healthcare professionals, industry executives, and regulatory stakeholders, complemented by field observations of distribution channels. Secondary data were sourced from peer-reviewed journals, trade publications, patent filings, and public health databases, enabling multi-source triangulation.

Quantitative modeling and segmentation frameworks were validated through cross-referencing supplier reports and global trade statistics. Regional market assessments incorporated localized regulatory guidelines and reimbursement policies, while thematic analysis identified emerging consumer preferences and technology adoption rates. Rigorous quality control protocols, including expert reviews and data audits, underpin the robustness of the findings, ensuring that this report reflects the most current and actionable intelligence available.

Synthesizing Insights for Informed Decision Making

The convergence of demographic shifts, regulatory evolutions, and technological breakthroughs underscores both the complexity and the opportunity inherent in the global contraceptive market. Detailed segmentation and regional analyses reveal nuanced demand drivers-from rising interest in non-hormonal solutions and digital health integration to the recalibration of supply chains under tariff pressures. Competitive profiling highlights that agility, evidence-based innovation, and patient engagement are pivotal to capturing market share and shaping long-term growth trajectories.

By translating these insights into targeted investments in R&D, strategic alliances, and adaptive go-to-market models, stakeholders can position themselves at the forefront of transformative change. The imperative now is to operationalize the recommendations, leveraging the comprehensive evidence base to make informed decisions that balance cost efficiency, regulatory compliance, and patient satisfaction.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • Emergency Contraceptives
      • IUDs
      • Pills
    • Hormonal
      • Implantable Contraceptives
      • Injectable Contraceptives
      • Oral Contraceptives
      • Transdermal Contraceptives
    • Non-Hormonal
      • Barrier Methods
      • Herbal Contraceptives
        • Ayurvedic
        • Homeopathic
      • Natural Methods
    • Permanent
      • Tubal Ligation
      • Vasectomy
  • Formulation
    • Patch
    • Pill
      • Monophasic
      • Multiphasic
    • Ring
  • Mode Of Action
    • Prevent Implantation
    • Spermicidal Action
    • Suppress Ovulation
  • Material Type
    • Latex-Based
    • Non-Latex
      • Nitrile
      • Polyisoprene
      • Polyurethane
  • Duration
    • Long-Term
    • Short-Term
  • Usage Frequency
    • On-Demand
    • Regular Use
  • Sales Channel
    • Offline
      • Hospital Pharmacy
      • Pharmacy
    • Online
      • E-Commerce Platforms
      • Online Pharmacy
  • Application
    • General Use
    • Post-Coital Use
  • End-User
    • Female
      • Adolescent
      • Adult
      • Post-Menopausal
    • Male
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbvie Inc.
  • Acme Generics Pvt. Ltd.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Amneal Pharmaceuticals LLC
  • ASKA Pharmaceutical Co., Ltd.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Church & Dwight Co., Inc.
  • Cipla Limited
  • HLL Lifecare Limited
  • Insud Pharma, S.L.
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals S.A.
  • Okamoto Industries, Inc.
  • Organon & Co.
  • Perrigo Company PLC
  • Pfizer Inc.
  • Piramal Pharma Ltd.
  • Reckitt Benckiser Group PLC
  • Ritex GmbH
  • Sanofi S.A.
  • Say It With A Condom, LLC
  • Syzygy Healthcare Solutions LLC
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD, Inc.
  • TTK Healthcare Limited
  • Veru Inc.
  • Viatris Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Contraceptive Market, by Type
8.1. Introduction
8.2. Emergency Contraceptives
8.2.1. IUDs
8.2.2. Pills
8.3. Hormonal
8.3.1. Implantable Contraceptives
8.3.2. Injectable Contraceptives
8.3.3. Oral Contraceptives
8.3.4. Transdermal Contraceptives
8.4. Non-Hormonal
8.4.1. Barrier Methods
8.4.2. Herbal Contraceptives
8.4.2.1. Ayurvedic
8.4.2.2. Homeopathic
8.4.3. Natural Methods
8.5. Permanent
8.5.1. Tubal Ligation
8.5.2. Vasectomy
9. Contraceptive Market, by Formulation
9.1. Introduction
9.2. Patch
9.3. Pill
9.3.1. Monophasic
9.3.2. Multiphasic
9.4. Ring
10. Contraceptive Market, by Mode Of Action
10.1. Introduction
10.2. Prevent Implantation
10.3. Spermicidal Action
10.4. Suppress Ovulation
11. Contraceptive Market, by Material Type
11.1. Introduction
11.2. Latex-Based
11.3. Non-Latex
11.3.1. Nitrile
11.3.2. Polyisoprene
11.3.3. Polyurethane
12. Contraceptive Market, by Duration
12.1. Introduction
12.2. Long-Term
12.3. Short-Term
13. Contraceptive Market, by Usage Frequency
13.1. Introduction
13.2. On-Demand
13.3. Regular Use
14. Contraceptive Market, by Sales Channel
14.1. Introduction
14.2. Offline
14.2.1. Hospital Pharmacy
14.2.2. Pharmacy
14.3. Online
14.3.1. E-Commerce Platforms
14.3.2. Online Pharmacy
15. Contraceptive Market, by Application
15.1. Introduction
15.2. General Use
15.3. Post-Coital Use
16. Contraceptive Market, by End-User
16.1. Introduction
16.2. Female
16.2.1. Adolescent
16.2.2. Adult
16.2.3. Post-Menopausal
16.3. Male
17. Americas Contraceptive Market
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. Argentina
18. Europe, Middle East & Africa Contraceptive Market
18.1. Introduction
18.2. United Kingdom
18.3. Germany
18.4. France
18.5. Russia
18.6. Italy
18.7. Spain
18.8. United Arab Emirates
18.9. Saudi Arabia
18.10. South Africa
18.11. Denmark
18.12. Netherlands
18.13. Qatar
18.14. Finland
18.15. Sweden
18.16. Nigeria
18.17. Egypt
18.18. Turkey
18.19. Israel
18.20. Norway
18.21. Poland
18.22. Switzerland
19. Asia-Pacific Contraceptive Market
19.1. Introduction
19.2. China
19.3. India
19.4. Japan
19.5. Australia
19.6. South Korea
19.7. Indonesia
19.8. Thailand
19.9. Philippines
19.10. Malaysia
19.11. Singapore
19.12. Vietnam
19.13. Taiwan
20. Competitive Landscape
20.1. Market Share Analysis, 2024
20.2. FPNV Positioning Matrix, 2024
20.3. Competitive Analysis
20.3.1. Abbvie Inc.
20.3.2. Acme Generics Pvt. Ltd.
20.3.3. Afaxys, Inc.
20.3.4. Agile Therapeutics, Inc.
20.3.5. Amneal Pharmaceuticals LLC
20.3.6. ASKA Pharmaceutical Co., Ltd.
20.3.7. Aurobindo Pharma Limited
20.3.8. Bayer AG
20.3.9. Church & Dwight Co., Inc.
20.3.10. Cipla Limited
20.3.11. HLL Lifecare Limited
20.3.12. Insud Pharma, S.L.
20.3.13. Johnson & Johnson Services, Inc.
20.3.14. Lupin Limited
20.3.15. Mayne Pharma Group Limited
20.3.16. Merck & Co., Inc.
20.3.17. Mithra Pharmaceuticals S.A.
20.3.18. Okamoto Industries, Inc.
20.3.19. Organon & Co.
20.3.20. Perrigo Company PLC
20.3.21. Pfizer Inc.
20.3.22. Piramal Pharma Ltd.
20.3.23. Reckitt Benckiser Group PLC
20.3.24. Ritex GmbH
20.3.25. Sanofi S.A.
20.3.26. Say It With A Condom, LLC
20.3.27. Syzygy Healthcare Solutions LLC
20.3.28. Teva Pharmaceutical Industries Ltd.
20.3.29. TherapeuticsMD, Inc.
20.3.30. TTK Healthcare Limited
20.3.31. Veru Inc.
20.3.32. Viatris Inc.
21. ResearchAI
22. ResearchStatistics
23. ResearchContacts
24. ResearchArticles
25. Appendix
List of Figures
FIGURE 1. CONTRACEPTIVE MARKET MULTI-CURRENCY
FIGURE 2. CONTRACEPTIVE MARKET MULTI-LANGUAGE
FIGURE 3. CONTRACEPTIVE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DURATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DURATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 22. GLOBAL CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL CONTRACEPTIVE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 24. GLOBAL CONTRACEPTIVE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 28. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 34. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HORMONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IMPLANTABLE CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INJECTABLE CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTRACEPTIVE MARKET SIZE, BY BARRIER METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTRACEPTIVE MARKET SIZE, BY AYURVEDIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HOMEOPATHIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTRACEPTIVE MARKET SIZE, BY NATURAL METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PERMANENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TUBAL LIGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTRACEPTIVE MARKET SIZE, BY VASECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PILL, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MONOPHASIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MULTIPHASIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTRACEPTIVE MARKET SIZE, BY RING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PREVENT IMPLANTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SPERMICIDAL ACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SUPPRESS OVULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONTRACEPTIVE MARKET SIZE, BY LATEX-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONTRACEPTIVE MARKET SIZE, BY NITRILE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CONTRACEPTIVE MARKET SIZE, BY POLYISOPRENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CONTRACEPTIVE MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CONTRACEPTIVE MARKET SIZE, BY LONG-TERM, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SHORT-TERM, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ON-DEMAND, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGULAR USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CONTRACEPTIVE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CONTRACEPTIVE MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENERAL USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CONTRACEPTIVE MARKET SIZE, BY POST-COITAL USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CONTRACEPTIVE MARKET SIZE, BY POST-MENOPAUSAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 112. CANADA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. CANADA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 114. CANADA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 115. CANADA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 116. CANADA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 117. CANADA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 118. CANADA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 119. CANADA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 120. CANADA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 121. CANADA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 122. CANADA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 123. CANADA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 124. CANADA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 125. CANADA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. CANADA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 127. CANADA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 128. CANADA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. CANADA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. CANADA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 131. MEXICO CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 133. MEXICO CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 134. MEXICO CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 135. MEXICO CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 136. MEXICO CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 137. MEXICO CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 138. MEXICO CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 139. MEXICO CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 140. MEXICO CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 141. MEXICO CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 142. MEXICO CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 143. MEXICO CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 144. MEXICO CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. MEXICO CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 146. MEXICO CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 147. MEXICO CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. MEXICO CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. MEXICO CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 184. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 220. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 224. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 227. GERMANY CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. GERMANY CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 229. GERMANY CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 230. GERMANY CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 231. GERMANY CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 232. GERMANY CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 233. GERMANY CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 234. GERMANY CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 235. GERMANY CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 236. GERMANY CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 237. GERMANY CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 238. GERMANY CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 239. GERMANY CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 240. GERMANY CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. GERMANY CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 242. GERMANY CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 243. GERMANY CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. GERMANY CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 245. GERMANY CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 246. FRANCE CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 247. FRANCE CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 248. FRANCE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 249. FRANCE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 250. FRANCE CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 251. FRANCE CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 252. FRANCE CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 253. FRANCE CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 254. FRANCE CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 255. FRANCE CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 256. FRANCE CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 257. FRANCE CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 258. FRANCE CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 259. FRANCE CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. FRANCE CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 261. FRANCE CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 262. FRANCE CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. FRANCE CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 264. FRANCE CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 276. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 277. RUSSIA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. RUSSIA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 280. RUSSIA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 281. RUSSIA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. RUSSIA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 283. RUSSIA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 284. ITALY CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 285. ITALY CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 286. ITALY CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 287. ITALY CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 288. ITALY CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 289. ITALY CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 290. ITALY CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 291. ITALY CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 292. ITALY CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 293. ITALY CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 294. ITALY CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 295. ITALY CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 296. ITALY CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 297. ITALY CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. ITALY CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 299. ITALY CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 300. ITALY CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. ITALY CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 302. ITALY CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 303. SPAIN CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 304. SPAIN CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 305. SPAIN CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 306. SPAIN CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 307. SPAIN CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 308. SPAIN CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 309. SPAIN CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 310. SPAIN CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 311. SPAIN CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 312. SPAIN CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 313. SPAIN CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 314. SPAIN CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 315. SPAIN CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 316. SPAIN CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. SPAIN CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 318. SPAIN CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 319. SPAIN CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. SPAIN CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 321. SPAIN CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 338. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 339. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 340. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 342. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 344. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 346. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 348. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 349. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY MODE OF ACTION, 2018-2030 (USD MILLION)
TABLE 350. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 351. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY NON-LATEX, 2018-2030 (USD MILLION)
TABLE 352. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DURATION, 2018-2030 (USD MILLION)
TABLE 353. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY USAGE FREQUENCY, 2018-2030 (USD MILLION)
TABLE 354. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 355. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 356. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 357. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 358. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 359. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 360. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 361. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY EMERGENCY CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 362. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2030 (USD MILLION)
TABLE 363. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, 2018-2030 (USD MILLION)
TABLE 364. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY HERBAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 365. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY PERMANENT, 2018-2030 (USD MILLION)
TABLE 366. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 367. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY PILL, 2018-2030 (USD MILLION)
TABLE 368. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY MO

Companies Mentioned

The companies profiled in this Contraceptive market report include:
  • Abbvie Inc.
  • Acme Generics Pvt. Ltd.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Amneal Pharmaceuticals LLC
  • ASKA Pharmaceutical Co., Ltd.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Church & Dwight Co., Inc.
  • Cipla Limited
  • HLL Lifecare Limited
  • Insud Pharma, S.L.
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals S.A.
  • Okamoto Industries, Inc.
  • Organon & Co.
  • Perrigo Company PLC
  • Pfizer Inc.
  • Piramal Pharma Ltd.
  • Reckitt Benckiser Group PLC
  • Ritex GmbH
  • Sanofi S.A.
  • Say It With A Condom, LLC
  • Syzygy Healthcare Solutions LLC
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD, Inc.
  • TTK Healthcare Limited
  • Veru Inc.
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 41.13 Billion
Forecasted Market Value ( USD ) by 2030 $ 58.98 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned33

Related Topics

Related Reports

Female Contraceptive Market by Product Type, Mechanism, Distribution Channel, Generation, End User Age, Price Range - Global Forecast to 2030 - Product Image

Female Contraceptive Market by Product Type, Mechanism, Distribution Channel, Generation, End User Age, Price Range - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Contraceptive Pills Market by Formulation, Packaging, Dosage Cycle, Pricing Tier, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Contraceptive Pills Market by Formulation, Packaging, Dosage Cycle, Pricing Tier, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Method (Pill, IUD), By Hormone (Combination Hormonal Contraceptives, Progestin-only), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030 - Product Image

Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Method (Pill, IUD), By Hormone (Combination Hormonal Contraceptives, Progestin-only), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Contraceptive Market Size, Share, & Trends Analysis Report By Product (Contraceptive Devices, Contraceptive Drugs), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Contraceptive Market Size, Share, & Trends Analysis Report By Product (Contraceptive Devices, Contraceptive Drugs), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From

About the Contraception Market

The Contraception market within the context of Personal Care Products is a large and diverse industry. It includes a wide range of products, from condoms and diaphragms to hormonal contraceptives such as the pill and intrauterine devices. Contraception is used to prevent pregnancy and is an important part of sexual health. It is also used to treat certain medical conditions, such as endometriosis. Contraception is widely available in pharmacies, supermarkets, and online. The market for contraception is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Church & Dwight, Bayer, Merck, Pfizer, and Allergan. Other companies include Cipla, Mylan, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.